Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.

Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, Kanno Y, Spalding C, Elloumi HZ, Paulson ML, Davis J, Hsu A, Asher AI, O'Shea J, Holland SM, Paul WE, Douek DC.

Nature. 2008 Apr 10;452(7188):773-6. doi: 10.1038/nature06764. Epub 2008 Mar 12.

2.

Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.

Al Khatib S, Keles S, Garcia-Lloret M, Karakoc-Aydiner E, Reisli I, Artac H, Camcioglu Y, Cokugras H, Somer A, Kutukculer N, Yilmaz M, Ikinciogullari A, Yegin O, Yüksek M, Genel F, Kucukosmanoglu E, Baki A, Bahceciler NN, Rambhatla A, Nickerson DW, McGhee S, Barlan IB, Chatila T.

J Allergy Clin Immunol. 2009 Aug;124(2):342-8, 348.e1-5. doi: 10.1016/j.jaci.2009.05.004. Epub 2009 Jul 3.

3.

Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome.

Renner ED, Rylaarsdam S, Anover-Sombke S, Rack AL, Reichenbach J, Carey JC, Zhu Q, Jansson AF, Barboza J, Schimke LF, Leppert MF, Getz MM, Seger RA, Hill HR, Belohradsky BH, Torgerson TR, Ochs HD.

J Allergy Clin Immunol. 2008 Jul;122(1):181-7. doi: 10.1016/j.jaci.2008.04.037.

4.

Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.

Woellner C, Gertz EM, Schäffer AA, Lagos M, Perro M, Glocker EO, Pietrogrande MC, Cossu F, Franco JL, Matamoros N, Pietrucha B, Heropolitańska-Pliszka E, Yeganeh M, Moin M, Español T, Ehl S, Gennery AR, Abinun M, Breborowicz A, Niehues T, Kilic SS, Junker A, Turvey SE, Plebani A, Sánchez B, Garty BZ, Pignata C, Cancrini C, Litzman J, Sanal O, Baumann U, Bacchetta R, Hsu AP, Davis JN, Hammarström L, Davies EG, Eren E, Arkwright PD, Moilanen JS, Viemann D, Khan S, Maródi L, Cant AJ, Freeman AF, Puck JM, Holland SM, Grimbacher B.

J Allergy Clin Immunol. 2010 Feb;125(2):424-432.e8. doi: 10.1016/j.jaci.2009.10.059.

5.

Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function.

Ives ML, Ma CS, Palendira U, Chan A, Bustamante J, Boisson-Dupuis S, Arkwright PD, Engelhard D, Averbuch D, Magdorf K, Roesler J, Peake J, Wong M, Adelstein S, Choo S, Smart JM, French MA, Fulcher DA, Cook MC, Picard C, Durandy A, Tsumura M, Kobayashi M, Uzel G, Casanova JL, Tangye SG, Deenick EK.

J Allergy Clin Immunol. 2013 Aug;132(2):400-11.e9. doi: 10.1016/j.jaci.2013.05.029. Epub 2013 Jul 4.

6.

Novel STAT3 mutation causing hyper-IgE syndrome: studies of the clinical course and immunopathology.

Sundin M, Tesi B, Sund Böhme M, Bryceson YT, Pütsep K, Chiang SC, Thunberg S, Winiarski J, Wikström AC.

J Clin Immunol. 2014 May;34(4):469-77. doi: 10.1007/s10875-014-0011-x. Epub 2014 Mar 14.

PMID:
24627079
7.

Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3.

Ma CS, Chew GY, Simpson N, Priyadarshi A, Wong M, Grimbacher B, Fulcher DA, Tangye SG, Cook MC.

J Exp Med. 2008 Jul 7;205(7):1551-7. doi: 10.1084/jem.20080218.

8.

Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency.

Minegishi Y, Karasuyama H.

Int Immunol. 2009 Feb;21(2):105-12. doi: 10.1093/intimm/dxn134. Epub 2008 Dec 15. Review.

9.

Th17 cells, Job's syndrome and HIV: opportunities for bacterial and fungal infections.

Milner JD, Sandler NG, Douek DC.

Curr Opin HIV AIDS. 2010 Mar;5(2):179-83. doi: 10.1097/COH.0b013e328335ed3e. Review.

10.

Defective trained immunity in patients with STAT-1-dependent chronic mucocutaneaous candidiasis.

Ifrim DC, Quintin J, Meerstein-Kessel L, Plantinga TS, Joosten LA, van der Meer JW, van de Veerdonk FL, Netea MG.

Clin Exp Immunol. 2015 Sep;181(3):434-40. doi: 10.1111/cei.12642. Epub 2015 Jul 7.

PMID:
25880788
11.

New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome.

Conti HR, Baker O, Freeman AF, Jang WS, Holland SM, Li RA, Edgerton M, Gaffen SL.

Mucosal Immunol. 2011 Jul;4(4):448-55. doi: 10.1038/mi.2011.5. Epub 2011 Feb 23.

12.

Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.

Siegel AM, Stone KD, Cruse G, Lawrence MG, Olivera A, Jung MY, Barber JS, Freeman AF, Holland SM, O'Brien M, Jones N, Nelson CG, Wisch LB, Kong HH, Desai A, Farber O, Gilfillan AM, Rivera J, Milner JD.

J Allergy Clin Immunol. 2013 Dec;132(6):1388-96. doi: 10.1016/j.jaci.2013.08.045. Epub 2013 Nov 1. Erratum in: J Allergy Clin Immunol. 2014 Apr;133(4):1232. Nelson, Celeste G [added].

13.

Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.

Boos AC, Hagl B, Schlesinger A, Halm BE, Ballenberger N, Pinarci M, Heinz V, Kreilinger D, Spielberger BD, Schimke-Marques LF, Sawalle-Belohradsky J, Belohradsky BH, Przybilla B, Schaub B, Wollenberg A, Renner ED.

Allergy. 2014 Jul;69(7):943-53. doi: 10.1111/all.12416.

PMID:
24898675
14.

Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis.

Schimke LF, Sawalle-Belohradsky J, Roesler J, Wollenberg A, Rack A, Borte M, Rieber N, Cremer R, Maass E, Dopfer R, Reichenbach J, Wahn V, Hoenig M, Jansson AF, Roesen-Wolff A, Schaub B, Seger R, Hill HR, Ochs HD, Torgerson TR, Belohradsky BH, Renner ED.

J Allergy Clin Immunol. 2010 Sep;126(3):611-7.e1. doi: 10.1016/j.jaci.2010.06.029. Erratum in: J Allergy Clin Immunol. 2010 Nov;126(5):1015.

PMID:
20816194
15.

Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.

Puel A, Cypowyj S, Maródi L, Abel L, Picard C, Casanova JL.

Curr Opin Allergy Clin Immunol. 2012 Dec;12(6):616-22. doi: 10.1097/ACI.0b013e328358cc0b. Review.

16.

Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes.

Freeman AF, Holland SM.

Pediatr Res. 2009 May;65(5 Pt 2):32R-37R. doi: 10.1203/PDR.0b013e31819dc8c5. Review.

17.

SH2-domain mutations in STAT3 in hyper-IgE syndrome patients result in impairment of IL-10 function.

Giacomelli M, Tamassia N, Moratto D, Bertolini P, Ricci G, Bertulli C, Plebani A, Cassatella M, Bazzoni F, Badolato R.

Eur J Immunol. 2011 Oct;41(10):3075-84. doi: 10.1002/eji.201141721. Epub 2011 Sep 6.

18.

An update on the hyper-IgE syndromes.

Yong PF, Freeman AF, Engelhardt KR, Holland S, Puck JM, Grimbacher B.

Arthritis Res Ther. 2012 Nov 30;14(6):228. doi: 10.1186/ar4069. Review.

19.

A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory.

Siegel AM, Heimall J, Freeman AF, Hsu AP, Brittain E, Brenchley JM, Douek DC, Fahle GH, Cohen JI, Holland SM, Milner JD.

Immunity. 2011 Nov 23;35(5):806-18. doi: 10.1016/j.immuni.2011.09.016.

20.

Expansion of T helper type 17 lymphocytes in patients with chronic granulomatous disease.

Horváth R, Rožková D, Lašťovička J, Poloučková A, Sedláček P, Sedivá A, Spíšek R.

Clin Exp Immunol. 2011 Oct;166(1):26-33. doi: 10.1111/j.1365-2249.2011.04449.x.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk